Here' my "n=1 / anecdote / was clearly bored" symptom diary of my #breakthrough#COVID19 case. And a short thread on things I found interesting about the disease process. (1/n)
My symptoms were not unique or special. They generally tracked with other reports on breakthrough delta infection in Isreal, Singapore, and US. Link to CDC report on Provincetown outbreak below as an example. (2/n)
Let's talk about rhinorrhea, or runny nose - worst I've ever had. Was almost comical how many paper tissues I burned through. Makes sense, as nasal epithelial cells and are prime targets of SARS-CoV-2--> damage+inflammation. (3/n)
About headache. Was less "head" and more "face pain". Centralized, behind nasal bridge and intense. Consistent with nasal epithelial injury. I like the title of this SARS-CoV-2 hamster study : "massive transient damage of olfactory epithelium"...yep! (4/n) ncbi.nlm.nih.gov/pmc/articles/P…
I'm most fascinated by loss of smell/taste. Some terms before expanding further:
Loss of smell (anosmia/hyposmia) is not that surprising and seen in other respiratory infections. Olfactory epithlial cells provide supportive functions to olfactory neurons. If epithelia is damaged, neurons don't get signals...smell gone. (6/n)
Loss of taste (ageusia) is more enigmatic. Taste independent of smell is sensing stimuli on tongue taste buds: salty/sour (via ion channels), bitter/sweet/umami (via G protein coupled receptors). Interesting to speculate how infection affects this.(7/n)
I initially lost smell but retained basic taste. Thankful for salt & vinegar! But then I lost those. For 36h, no taste of any kind whatsoever. It returned quickly, but loss of smell still precluded "flavor-based" taste. I'm at ~50% loss in that regard, gratefully improving.(8/n)
Loss of smell/taste is also a problem in #longCOVID. While other COVID symptoms are more debilitating, the emotional toll of lost taste/smell should not be minimized. Looking forward to new research in this area. (9/n) thelancet.com/journals/eclin…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Through virologic, biochemical, and cell biological approaches, Wenchun found that TRIM7 functions as an E3 ligase that targets enterovirus 2BC for ubiquitination and proteasome-dependent degradation. This wipes out viral replication. 2/7
He then isolated in cell culture a coxsackievirus B3 variant that is resistant to TRIM7 effects. The variant virus contains a single point mutation T323A in viral 2C. This allows 2BC to evade TRIM7 binding. But it also results in an altered 2C protein. 3/7
Never thought we’d contribute to clinical trial for COVID-19, but here we are. With @HeshamS70605263 team, we found FDA-approved drugs that curb SARS-CoV-2 in cells. Clinical trial pending approval. Study in Chemrxiv. Details in thread. 1/10 doi.org/10.26434/chemr… via @figshare
Here’s how it happened. @HeshamS70605263 team used computers (‘molecular docking’) to find FDA-approved drugs that might target a SARS-CoV-2 protein. Like a key fitting into a lock. If the drug fit, it might hinder the virus. 2/10
They combed through 2000 FDA-approved drugs and whittled the list down to ~24 drugs that looked like promising candidates for repurposing as antivirals for SARS-CoV-2/COVID-19. 3/10